Figure - available from: Rheumatology International
This content is subject to copyright. Terms and conditions apply.
Timeline of disease progression from myasthenia gravis to development of connective tissue disease. PRED prednisone, MMF mycophenolate mofetil, PYR pyridostigmine, IVIG intravenous immunoglobulin, HCQ hydroxychloroquine, DDS dapsone (4,4¹ diaminodiphenylsulfate), PLEX plasma exchange, HSCT hematopoietic stem cell transplant

Timeline of disease progression from myasthenia gravis to development of connective tissue disease. PRED prednisone, MMF mycophenolate mofetil, PYR pyridostigmine, IVIG intravenous immunoglobulin, HCQ hydroxychloroquine, DDS dapsone (4,4¹ diaminodiphenylsulfate), PLEX plasma exchange, HSCT hematopoietic stem cell transplant

Source publication
Article
Full-text available
Connective tissue diseases, including systemic lupus erythematosus (SLE) and systemic sclerosis are classic models of autoimmunity; diseases with large-scale loss of tolerance and subsequent development of pathogenic autoreactive lymphocytes and tissue targeting autoantibodies. Here we report a case of mixed connective tissue disease, with features...

Similar publications

Article
Full-text available
This cross-sectional online study was designed by the study group on Capillaroscopy and Microcirculation in Rheumatic Diseases (CAP) of the Italian Society of Rheumatology (SIR) to provide an overview of the management of nailfold capillaroscopy in Italian rheumatology centers. Therefore, SIR distributed the survey to its members in July 2021, and...

Citations

Article
Full-text available
The thymus gland aids in the maturation of the immune system. An overactive or malfunctioning thymus gland, as seen in thymomas, can lead to disrupted immune systems. Thymectomy, the usual treatment, can paradoxically lead to further derangements in the immune system, leading to new autoimmune disorders. Most of these reported disorders are rheumatological. Except preclinical studies, there are no reported cases of autoimmune diabetes post-thymectomy. A 25-year-old woman who had malignant thymoma underwent chemotherapy, followed by thymectomy and radiotherapy. She developed autoimmune diabetes mellitus (AID) approximately 1 year post-thymectomy, evident from raised glycated hemoglobin, anti-glutamic acid decarboxylase (GAD) antibodies, ineffectiveness of oral glucose-lowering agents, and positive response to insulin. AID can occur after thymectomy, as evidenced by animal studies and this case report. Whether these patients would have long-term outcomes and control of diabetes differently than classic type 1 diabetes mellitus (T1D) is uncertain. Further research is needed to prove causality between thymectomy and diabetes.